Big Lots Bunk Bed Recall: Risk of Bed Collapsing

|

About 20,000 Big Lots bunk beds are being recalled due to defective supports which can crack or break, causing the bunk bed to collapse and potentially cause a personal injury for children or their parents.

The Big Lots bunk bed recall was announced on Wednesday by the U.S. Consumer Product Safety Commission (CPSC), which indicated that bunk beds’ mattress support slats and side support rails have been found to be defective and could fail. At least 14 reports have been received involving cracking or breaking of the support slats, and at least four injuries have occurred.

The wooden bunk beds were sold at Big Lots stores throughout the United States between May 2008 and February 2009 for about $300. They contain a three step ladder, with model numbers WP-9108-1 or WP-9108-2 located on a sticker on the interior panel of the headboard or footboard of the bed.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

Consumers are advised to immediately stop using the bunk beds and should contact Big Lots to return the defective parts and receive a free repair kit. Consumers can contact Big Lots at 1-866-244-5687 or visit the company’s website at www.biglots.com.


0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

A new lawsuit against Roblox alleges that the platform’s inadequate safety measures enabled multiple sexual predators to exploit a five-year-old girl.
Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm.
Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety.